"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 19

Issue 19 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
26 May 2011
Business
2 of 4 Previous | Next
Business

Puerto Rico: A natural choice for pharmaceutical meetings


When people think about Puerto Rico, images of pristine beaches, historic cities surrounded by Spanish forts and sweeping Caribbean views and an effervescent culture of people filled with pride for their heritage and people quickly come to mind.

No Comments

New Jersey remains highly desirable location for life sciences businesses


New Jersey has a richly deserved reputation as a pioneering state for biotechnology and the life sciences. A talented workforce that makes the state a leader in innovation, research and development and New Jersey’s location in the heart of one of the world’s larger and more vibrant workplaces between New York City and Philadelphia are among its principal strengths.

No Comments

Deciding which projects to fund


Many important problems faced by decision makers involve multiple conflicting objectives. When faced with truly difficult decisions involving high stakes, risky and conflicting objectives, this transparent approach will help to guide decision makers toward better, more defensible choices.

No Comments

Physician Payments Sunshine Act


A perspective on the hidden value of the Physician Payments Sunshine Act.

Next generation feasibility assessments


Admit it. You know that sending out site feasibility surveys doesn’t work to secure high performing investigative sites for your trial but “this is the way it’s always been done.” In this article we’ll explore why investigative site surveys are not predictive of actual site performance and what you can do to transform your feasibility assessment process to improve site selection and study execution.

2 of 4 Previous | Next